Home › Interstitial Lung Diseases › Missouri
Pag-aaral pangklinika para sa Interstitial Lung Diseases sa Missouri
6 pag-aaral para sa Interstitial Lung Diseases ang naghahanap ng mga kalahok sa mga site sa Missouri.
Mga Lungsod sa Missouri
Opisyal na teksto ng pag-aaral (English)
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- The Lung Research Center, LLC, Chesterfield
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06968845Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Washington University, St Louis
Nagre-recruitObservasyonal na pag-aaral
Edad 21 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT01915511Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Hannibal Regional Healthcare System, Hannibal
- Mercy Hospital Springfield, Springfield
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06911632A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, St Louis
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06572384DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Washington University School of Medicine, St Louis
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT06388421Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- The Lung Research Center, LLC, Chesterfield
- Saint Luke's Hospital of Kansas City, Kansas City
- Washington University School of Medicine, St Louis
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT05943535Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.